Biomarker development targeting unmet clinical needs-Reference-Cited by-同舟云学术

Biomarker development targeting unmet clinical needs

Published:2016-09 Issue: Volume:460 Page:211-219
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Monaghan Phillip J.,Lord Sarah J.,St John Andrew,Sandberg Sverre,Cobbaert Christa M.,Lennartz Lieselotte,Verhagen-Kamerbeek Wilma D.J.,Ebert Christoph,Bossuyt Patrick M.M.,Horvath Andrea R.

Funder

European Federation of Clinical Chemistry and Laboratory Medicine

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference21 articles.

1. Biomedical research: increasing value, reducing waste;Macleod;Lancet,2014

2. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?;Diamandis;BMC Med.,2012

3. Biomarker failures;Ioannidis;Clin. Chem.,2013

4. Screening for prostate cancer: U.S. preventive services task force recommendation statement;Moyer;Ann. Intern. Med.,2012

5. Prostate cancer screening;Eggener;JAMA,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative protein mass spectrometry for multiplex measurement of coagulation and fibrinolytic proteins towards clinical application: What, why and how?;Thrombosis Research;2024-09

2. Current State of Research on Potential Biomarkers for Trisomy18 and 21 in Pregnancy Screening;Journal of Disability Research;2024-04-19

3. The Role of Clinical Glyco(proteo)mics in Precision Medicine;Molecular & Cellular Proteomics;2023-06

4. Lipidomics in Clinical Diagnostics;Mass Spectrometry for Lipidomics;2023-03-10

5. ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European In-Vitro-Diagnostics Regulation;Clinical Chemistry and Laboratory Medicine (CCLM);2023-01-31